Detalles de la búsqueda
1.
Risk of hospitalization and death due to infection in people with psoriasis: a population-based cohort study using the Clinical Practice Research Datalink.
Br J Dermatol;
184(1): 78-86, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32222069
2.
Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a scoping review of dermatology clinical practice guidelines.
Br J Dermatol;
185(4): 736-744, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33937976
3.
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
Br J Dermatol;
185(1): 80-90, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33368145
4.
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Br J Dermatol;
183(2): 294-302, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32124442
5.
Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis.
Br J Dermatol;
183(4): 638-649, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562551
6.
Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal.
Br J Dermatol;
180(6): 1348-1351, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30632140
7.
Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy.
Br J Dermatol;
180(4): 894-901, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30430546
8.
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
Br J Dermatol;
180(2): 329-337, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30070708
9.
A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis.
Br J Dermatol;
181(6): 1265-1271, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30822358
10.
Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review.
Br J Dermatol;
181(2): 256-264, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30628069
11.
Checking for update living systematic reviews and clinical practice guidelines in the BJD.
Br J Dermatol;
186(5): 761-762, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35501944
12.
Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials.
Br J Dermatol;
176(4): 890-901, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27518205
13.
Algorithm-based smartphone apps to assess risk of skin cancer in adults: critical appraisal of a systematic review.
Br J Dermatol;
184(4): 638-639, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32866990
14.
Can artificial intelligence be used for accurate remote scoring of the Psoriasis Area and Severity Index in adult patients with plaque psoriasis?
Br J Dermatol;
185(6): 1262-1264, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351616
15.
Early- and late-onset psoriasis: a cross-sectional clinical and immunocytochemical investigation.
Br J Dermatol;
175(5): 1038-1044, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27459949
16.
Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single-centre cross-sectional study.
Br J Dermatol;
185(2): 441-443, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33730411
17.
Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory disease.
Br J Dermatol;
185(3): 646-648, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33982284
18.
Paradoxical exacerbation of chronic plaque psoriasis by sorafenib.
Clin Exp Dermatol;
41(4): 407-9, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26667599
19.
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.
J Eur Acad Dermatol Venereol;
35(10): e636-e640, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34145643
20.
Repurposing existing trial data to infer relative efficacy of biologics: guselkumab vs. ustekinumab for psoriasis.
Br J Dermatol;
183(2): 202-203, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943131